Researchers from Israel headed by Nobel laureate
Ada E. Yonath is set to develop an effective drug to fight disease resistant pathogens,
The genetic solution to the menace of antibiotic resistance to a plethora of diseases such as TB and hospital acquired infections, it targets a bacteria called methicillin-resistant Staphylococcus aureus (MRSA).
Pathogens developing resistance to antibiotics are a real threat.
The novel molecule called Lefamulin has been found to treat diseases resistant to set of antibiotics.
This drug targets pneumonia.
Staphylococcus aureus is fast developing resistance.
This is causing new infections to patients.
Role of ribosomes to develop new generation antibiotics is being highlighted.
What are Antibiotics Drugs?Antibiotics and similar drugs, together are called
antimicrobial agents.
They have been used for the last 70 years to treat patients who have infectious diseases.
Since the 1940s, these drugs have greatly reduced illness and death from infectious diseases.
But, with the rise of antimicrobial resistance, the drugs are losing their impact.
